tiprankstipranks
Advertisement
Advertisement

ORGO Stock Latest News

Organogenesis management to meet with BTIG
The FlyOrganogenesis management to meet with BTIG
15d ago
ORGO
Organogenesis Earnings Call: Record Highs Meet Policy Shock
PremiumCompany Announcements
Organogenesis Earnings Call: Record Highs Meet Policy Shock
27d ago
ORGO
Organogenesis price target lowered to $8 from $9 at BTIG
PremiumThe Fly
Organogenesis price target lowered to $8 from $9 at BTIG
30d ago
ORGO
Organogenesis Names Patrick McGuire Chief Accounting Officer
PremiumCompany Announcements
Organogenesis Names Patrick McGuire Chief Accounting Officer
1M ago
8K
ORGO
Organogenesis Extends Long-Term Leases for Key Facilities
PremiumCompany Announcements
Organogenesis Extends Long-Term Leases for Key Facilities
3M ago
8K
ORGO
Closing Bell Movers: UiPath up nearly 4% after S&P 400 admission
PremiumThe FlyClosing Bell Movers: UiPath up nearly 4% after S&P 400 admission
3M ago
AMZN
GOOG
Organogenesis initiates rolling submission of BLA to FDA for ReNu
Premium
The Fly
Organogenesis initiates rolling submission of BLA to FDA for ReNu
3M ago
ORGO
Organogenesis Nears Key Data Milestone With Phase 3 Knee Osteoarthritis Study
Premium
Company Announcements
Organogenesis Nears Key Data Milestone With Phase 3 Knee Osteoarthritis Study
3M ago
ORGO
Morning Movers: Vital Farms dips after cutting FY25 revenue view
PremiumThe Fly
Morning Movers: Vital Farms dips after cutting FY25 revenue view
3M ago
F
F
Buy Rating for Organogenesis Holdings: FDA Progress and Favorable Policy Changes Drive Optimism
PremiumRatings
Buy Rating for Organogenesis Holdings: FDA Progress and Favorable Policy Changes Drive Optimism
3M ago
ORGO
Organogenesis plans to file BLA for ReNu before end of December
PremiumThe Fly
Organogenesis plans to file BLA for ReNu before end of December
3M ago
ORGO
Organogenesis price target raised to $9 from $7 at BTIG
PremiumThe Fly
Organogenesis price target raised to $9 from $7 at BTIG
4M ago
ORGO
Organogenesis Holdings Surpasses Revenue Guidance Amid Challenges
PremiumCompany AnnouncementsOrganogenesis Holdings Surpasses Revenue Guidance Amid Challenges
5M ago
ORGO
Organogenesis Holdings Reports Record Revenue, Raises Guidance
Premium
Company Announcements
Organogenesis Holdings Reports Record Revenue, Raises Guidance
5M ago
ORGO
Organogenesis Holdings’ New Study on Diabetic Foot Ulcers: A Potential Game-Changer?
Premium
Company Announcements
Organogenesis Holdings’ New Study on Diabetic Foot Ulcers: A Potential Game-Changer?
5M ago
ORGO
Buy Rating for Organogenesis Holdings Despite Mixed Trial Results, Supported by Diversified Revenue and FDA Clearance Efforts
PremiumRatings
Buy Rating for Organogenesis Holdings Despite Mixed Trial Results, Supported by Diversified Revenue and FDA Clearance Efforts
6M ago
ORGO
Organogenesis Holdings Faces Setback in ReNu Phase 3 Trial
PremiumCompany Announcements
Organogenesis Holdings Faces Setback in ReNu Phase 3 Trial
6M ago
8K
ORGO
Organogenesis provides update on second Phase 3 ReNu study
PremiumThe Fly
Organogenesis provides update on second Phase 3 ReNu study
6M ago
ORGO
Buy Rating for Organogenesis Holdings Amid Favorable Medicare Pricing and Market Positioning
PremiumRatings
Buy Rating for Organogenesis Holdings Amid Favorable Medicare Pricing and Market Positioning
7M ago
ORGO
Organogenesis Holdings’ Earnings Call: Mixed Sentiments and Strategic Moves
PremiumCompany AnnouncementsOrganogenesis Holdings’ Earnings Call: Mixed Sentiments and Strategic Moves
8M ago
ORGO
Organogenesis Holdings Reports Mixed Q2 2025 Results
Premium
Company Announcements
Organogenesis Holdings Reports Mixed Q2 2025 Results
8M ago
ORGO
Organogenesis Amends Credit Agreement Amid Revenue Decline
Premium
Company Announcements
Organogenesis Amends Credit Agreement Amid Revenue Decline
8M ago
8K
ORGO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >